Surgery for Pancreatic Cancer
A special issue of Journal of Clinical Medicine (ISSN 2077-0383). This special issue belongs to the section "Gastroenterology & Hepatopancreatobiliary Medicine".
Deadline for manuscript submissions: closed (25 July 2023) | Viewed by 3357
Special Issue Editor
Interests: pancreatoblastoma; pancreaticoduodenectomy; pancreas; pancreas adenocarcinoma; neoadjuvant therapy; hepatic artery; mesenteric veins
Special Issue Information
Dear Colleagues,
Pancreatic cancer is the most common highly malignant tumor of the pancreas. Surgical resection is the only possible cure for patients with pancreatic cancer. However, the initial resection rate is only 20% because the cancer has already metastasized or is in the locally advanced stage when it is detected. Although the resection rate and surgical safety of pancreatic cancer have been improved in recent years, the long-term survival of patients has not been significantly improved. It is unrealistic to improve the 5-year survival rate simply through surgery. The probability of recurrence and metastasis in pancreatic cancer patients after surgery is very high, even in the early stage. This provides a theoretical basis for the neoadjuvant therapy for this devastating disease. The proportion of patients with pancreatic cancer receiving neoadjuvant therapy is increasing each year. Traditional "surgery first" treatment strategy, which is appropriate for resectable pancreatic cancer, is now facing doubts and challenges, especially for locally advanced and borderline resectable pancreatic cancer. Additionally, with the development of surgical techniques and instruments, the minimally invasive surgical treatment of pancreatic cancer has achieved unprecedented development.
In this Special Issue, we will pay attention to a variety of surgical treatment strategies in pancreatic cancer, including preoperative and postoperative management (such as neoadjuvant chemoradiotherapy, the prevention of postoperative complications, nutritional supplement and other perioperative management), and methods to prevent postoperative recurrence and metastasis.
Dr. Feng Yang
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- pancreatic cancer
- pancreaticoduodenectomy
- distal pancreatectomy
- neoadjuvant therapy
- pancreatic fistula
- minimally invasive surgery
